Elevation Point Wealth Partners LLC Has $3.62 Million Stock Holdings in CME Group Inc. $CME

Elevation Point Wealth Partners LLC lifted its stake in shares of CME Group Inc. (NASDAQ:CME) by 728.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,272 shares of the financial services provider’s stock after acquiring an additional 10,790 shares during the quarter. Elevation Point Wealth Partners LLC’s holdings in CME Group were worth $3,625,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Norges Bank bought a new stake in CME Group during the fourth quarter valued at $1,523,241,000. Sanders Capital LLC bought a new position in shares of CME Group in the 3rd quarter worth about $1,006,932,000. Victory Capital Management Inc. raised its position in shares of CME Group by 746.4% in the 4th quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock worth $559,720,000 after acquiring an additional 1,807,491 shares in the last quarter. Life Cycle Investment Partners Ltd acquired a new position in shares of CME Group in the 4th quarter valued at about $217,656,000. Finally, Viking Global Investors LP acquired a new position in shares of CME Group in the 2nd quarter valued at about $164,648,000. 87.75% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently commented on CME shares. Keefe, Bruyette & Woods raised CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price for the company in a research note on Thursday, June 18th. Barclays cut their price target on CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a report on Thursday, April 23rd. UBS Group reaffirmed an “overweight” rating on shares of CME Group in a research report on Monday, June 15th. The Goldman Sachs Group lowered their price objective on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Twelve equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, CME Group currently has an average rating of “Moderate Buy” and a consensus price target of $300.94.

CME Group Stock Performance

NASDAQ CME opened at $236.60 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16. The business has a 50 day moving average price of $267.17 and a 200-day moving average price of $284.28. The company has a market cap of $85.73 billion, a price-to-earnings ratio of 20.19, a P/E/G ratio of 2.65 and a beta of 0.25.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.77 billion. During the same period last year, the business earned $2.80 EPS. CME Group’s quarterly revenue was up 14.5% compared to the same quarter last year. As a group, equities analysts expect that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is currently 44.37%.

Insider Activity

In other CME Group news, Director William R. Shepard bought 325 shares of the firm’s stock in a transaction dated Thursday, June 25th. The stock was bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares in the company, valued at $16,606,111.30. This represents a 38.62% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.